Lakefront Biotherapeutics (LKFT) Revenue Growth (3y) (2017 - 2026)
Lakefront Biotherapeutics (LKFT) Revenue Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 50.07% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | -51.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.99% |
| Dec 31, 2025 | 70.81% |
| Sep 30, 2025 | 41.55% |
| Jun 30, 2025 | 45.98% |
| Mar 31, 2025 | 73.28% |
| Dec 31, 2024 | -63.07% |
| Sep 30, 2024 | 214.02% |
| Jun 30, 2024 | -33.25% |
| Mar 31, 2024 | -91.45% |
| Dec 31, 2023 | -40.39% |
| Sep 30, 2023 | -42.50% |
| Jun 30, 2023 | -15.53% |
| Mar 31, 2023 | -17.31% |
| Dec 31, 2022 | 18.30% |
| Sep 30, 2022 | -67.81% |
| Jun 30, 2022 | -29.04% |
| Mar 31, 2022 | -24.17% |
| Dec 31, 2021 | 22.16% |
| Sep 30, 2021 | -62.99% |
| Jun 30, 2021 | 30.42% |